FDA's Proposed Rule for Oversight of Laboratory Developed Tests: Part II: FDA's Proposed Phaseout Policy - Key Considerations & Open Questions | Goodwin
After an over decade-long discourse amongst interested stakeholders, on October 3, 2023, FDA unveiled its proposed rule and policy to increase oversight over LDTs. If...
Clinical Laboratory Improvement Amendments Public Health Surveillance Academic Medical Centers Amcs Veterans Health Administration Tests Subject Phaseout Policy
Source: jdsupra.com